Teva- Pharmaceutical Industries Ltd. - ADR

NYSE:TEVA   4:00:00 PM EDT
16.76
0.00 (0.00%)
7:51:10 PM EDT: $16.65 -0.11 (-0.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.22B
Current PEN/A
Forward PE 6.6
2yr Forward PE 6.07
See more stats
Estimates Current Quarter
Revenue$4.3 Billion
Adjusted EPS$0.64
See more estimates
10-Day MA$16.94
50-Day MA$16.65
200-Day MA$17.45
See more pivots

Teva- Pharmaceutical Industries Ltd. - ADR Stock, NYSE:TEVA

124 Dvora HaNevi'a Street, Tel Aviv, Tel Aviv 6944020
Israel
Phone: +972.3.914.8213
Number of Employees: 36167

Description

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.